Skyeline Management Ltd, 10% Owner at Royalty Pharma plc (RPRX), sold 500 shares at $44.00 ($22K) on 2022-08-25, disclosed to the SEC on 2022-08-29.
Open-market sale of $22k RPRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.